# Univercells Technologies

sells the scale-X platform, a fixed-bed perfusion bioreactor line scaling from a 0.5 m² scale-X nexo research system to a 600 m² scale-X nitro commercial-manufacturing configuration for vaccine and viral-vector production, engineered to overcome the scale-up limitations of traditional stirred-tank culture.


Source: https://cn.bioecon.ru/companies/univercells-technologies/
Updated: 2026-08-14

- 国家: Belgium

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 成立 | 2020年 | https://www.univercellstech.com/univercells-technologies-completes-nivelles-facility-expansion-tripling-manufacturing-and-rd-capacity/ |
| 总部 | 比利时Nivelles | https://www.donaldsonlifesciences.com/content/lifesciences/en/news/donaldson-acquires-univercells-technologies--broadens-life-scien.html, https://www.univercellstech.com/donaldson-acquires-univercells-technologies-broadens-life-sciences-reach/ |
| 生产基地 | 比利时Nivelles | https://www.univercellstech.com/univercells-technologies-completes-nivelles-facility-expansion-tripling-manufacturing-and-rd-capacity/ |
| 产能 | 生物反应器产品线从0.5平方米（nexo）扩展至200-600平方米（nitro） | https://www.univercellstech.com/demystifying-the-scale-x-nitro-bioreactor-answering-your-burning-questions/, https://www.univercellstech.com/products/, https://www.univercellstech.com/products/scale-x-carbo/, https://www.univercellstech.com/products/scale-x-nexo-system/, https://www.univercellstech.com/products/scale-x-nitro-system/, https://www.univercellstech.com/univercells-technologies-by-donaldson-launches-thescale-x-nexo-mini-bioreactor-for-cost-efficient-scalable-cell-culture-process-development-across-modalities/ |
| 认证 | 生物反应器经伽马辐照灭菌，并附完整的GMP条件验证指南 | https://www.univercellstech.com/demystifying-the-scale-x-nitro-bioreactor-answering-your-burning-questions/ |
| 监管批准 | 该技术用于在FDA与EMA监管下按GMP生产临床用物料；NevoLine平台可满足21CFR part 11合规要求 | https://www.univercellstech.com/demystifying-the-scale-x-nitro-bioreactor-answering-your-burning-questions/ |
| 员工人数 | 截至2025年62.5全职当量；截至2026年7月68名员工 | https://www.companyweb.be/en/0741506996/univercells-technologies |
| 营收 | 约€1000万（2022日历年度）；€6,090,844（2025年财务报表） | https://www.companyweb.be/en/0741506996/univercells-technologies, https://www.univercellstech.com/donaldson-acquires-univercells-technologies-broadens-life-sciences-reach/ |

独立来源: companyweb.be, donaldsonlifesciences.com

## 技术

- [种子培养链自动化系统](https://cn.bioecon.ru/technology/seed-train-automation-systems/)
- [高密度细胞培养系统](https://cn.bioecon.ru/technology/high-cell-density-culture-systems/)